This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Simon E Johnson - Innovator in Pharmaceutical Chemistry
Introduction
Simon E Johnson is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds.
Latest Patents
Simon holds a patent for "Piperazine derivatives as MAGL inhibitors." This invention provides new heterocyclic compounds characterized by a general Formula (I), or a pharmaceutically acceptable salt thereof. His work in this area has the potential to impact therapeutic strategies significantly.
Career Highlights
Simon is currently employed at Hoffmann-La Roche Inc., a leading global healthcare company. His role involves extensive research and development, focusing on innovative solutions in drug discovery and development.
Collaborations
Throughout his career, Simon has collaborated with esteemed colleagues, including Joerg Benz and Uwe Grether. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Simon E Johnson's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in drug development. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile